CLINICAL_TRIALS
trial_result
· 2015-08-28
Clinical Trial Update: Asian Phase I Study Of PF-03446962 [Phase 1]
Summary
Pfizer reports results from an Asian Phase I study of PF-03446962 in neoplasms, with the trial status showing completion and results posted in 2015.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Neoplasms | Phase 1 | Status: COMPLETED | Results posted: 2015-08-28